GMOA tabled the concept paper prepared by Prof Kamini Mendis on the treatment of COVID-19 patients with HCQ and Azithromycin in Task Force meeting today.
- Memorandum on Treatment guidelines for COVID-19 patients in Sri Lanka based on Hydroxychloroquine – Download
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro – Download
- Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 – Download
- HCQ and Azithromycin as treatment of COVID-19 – Download